Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial.
Saved in:
| Title: | Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. |
|---|---|
| Authors: | Broom RJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand. Electronic address: ReubenB@adhb.govt.nz., Hinder V; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Sharples K; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand; Department of Preventative and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Proctor J; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Duffey S; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Pollard S; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Fong PC; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Forgeson G; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North, New Zealand., Harris DL; Oncology Service, Christchurch Hospital, Christchurch, New Zealand., Jameson MB; Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand., O'Donnell A; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., North RT; Tauranga Hospital, Tauranga, New Zealand., Deva S; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Hanning FJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Grey A; Department of Medicine, University of Auckland, Auckland, New Zealand., Findlay MP; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand. |
| Source: | Clinical genitourinary cancer [Clin Genitourin Cancer] 2015 Feb; Vol. 13 (1), pp. 50-8. Date of Electronic Publication: 2014 Jul 15. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25163397 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Broom+RJ%22">Broom RJ</searchLink>; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand. Electronic address: ReubenB@adhb.govt.nz.<br /><searchLink fieldCode="AU" term="%22Hinder+V%22">Hinder V</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sharples+K%22">Sharples K</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand; Department of Preventative and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Proctor+J%22">Proctor J</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Duffey+S%22">Duffey S</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Pollard+S%22">Pollard S</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Fong+PC%22">Fong PC</searchLink>; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Forgeson+G%22">Forgeson G</searchLink>; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North, New Zealand.<br /><searchLink fieldCode="AU" term="%22Harris+DL%22">Harris DL</searchLink>; Oncology Service, Christchurch Hospital, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Jameson+MB%22">Jameson MB</searchLink>; Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22O'Donnell+A%22">O'Donnell A</searchLink>; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22North+RT%22">North RT</searchLink>; Tauranga Hospital, Tauranga, New Zealand.<br /><searchLink fieldCode="AU" term="%22Deva+S%22">Deva S</searchLink>; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hanning+FJ%22">Hanning FJ</searchLink>; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Grey+A%22">Grey A</searchLink>; Department of Medicine, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Findlay+MP%22">Findlay MP</searchLink>; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101260955%22">Clinical genitourinary cancer</searchLink> [Clin Genitourin Cancer] 2015 Feb; Vol. 13 (1), pp. 50-8. <i>Date of Electronic Publication: </i>2014 Jul 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101260955 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215587673%22">15587673 </searchLink><i>NLM ISO Abbreviation: </i>Clin Genitourin Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25163397 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clgc.2014.07.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 50 Titles: – TitleFull: Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Broom RJ – PersonEntity: Name: NameFull: Hinder V – PersonEntity: Name: NameFull: Sharples K – PersonEntity: Name: NameFull: Proctor J – PersonEntity: Name: NameFull: Duffey S – PersonEntity: Name: NameFull: Pollard S – PersonEntity: Name: NameFull: Fong PC – PersonEntity: Name: NameFull: Forgeson G – PersonEntity: Name: NameFull: Harris DL – PersonEntity: Name: NameFull: Jameson MB – PersonEntity: Name: NameFull: O'Donnell A – PersonEntity: Name: NameFull: North RT – PersonEntity: Name: NameFull: Deva S – PersonEntity: Name: NameFull: Hanning FJ – PersonEntity: Name: NameFull: Grey A – PersonEntity: Name: NameFull: Findlay MP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2015 Feb Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1938-0682 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Clinical genitourinary cancer Type: main |
| ResultId | 1 |